ARE NEUROPHYSIOLOGICAL PARAMETERS AN OBJECTIVE MEASURE OF DISEASE STATUS AND PROGRESSION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS?

被引：0
|
作者：
Witherick, J.
Kane, N.
Butler, S.
Walsh, P.
Blake, K.
Faulkner, H.
Burrows, J.
Inglis, K.
Cottrell, D.
机构：
[1] N Bristol NHS Trust, Frenchay Hosp, Dept Neurol, Bristol, Avon, England
[2] N Bristol NHS Trust, Frenchay Hosp, Dept Neurophysiol, Bristol, Avon, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2012年 / 83卷 / 03期
关键词：
D O I：
10.1136/jnnp-2011-301993.194
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Spinal cord atrophy as a primary outcome measure in primary progressive multiple sclerosis neuroprotective trials
    Cawley, N.
    Abdel-Aziz, K.
    Schneider, T.
    Altmann, D.
    Wheeler-Kingshott, C. A. M.
    Miller, D. H.
    Thompson, A. J.
    Ciccarelli, O.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 189 - 190
  • [42] A multiple sclerosis disease progression measure based on rate of cumulative disability
    Manouchehrinia, A.
    Hillert, J.
    Ramanujam, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 79 - 80
  • [43] Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis
    Letizia Leocani
    Arturo Nuara
    Elise Houdayer
    Irene Schiavetti
    Ubaldo Del Carro
    Stefano Amadio
    Laura Straffi
    Paolo Rossi
    Vittorio Martinelli
    Carlos Vila
    Maria Pia Sormani
    Giancarlo Comi
    [J]. Journal of Neurology, 2015, 262 : 2520 - 2527
  • [44] Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis
    Aymerich, F. X.
    Auger, C.
    Alonso, J.
    Alberich, M.
    Sastre-Garriga, J.
    Tintore, M.
    Montalban, X.
    Rovira, A.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (02) : 399 - 404
  • [45] The lymphocyte subpopulation in patients with primary progressive multiple sclerosis and secondary progressive multiple sclerosis
    Belniak, Ewa
    Bojarska-Junak, Agnieszka
    Bartosik-Psujek, Halina
    Mitosek-Szewezyk, Krystyna
    Kulka, Malgorzata
    Stelmasiak, Zbigniew
    Rolinski, Jacek
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S116 - S116
  • [46] Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis
    Ferreira Vasconcelos, Claudia Cristina
    Fernandez, Oscar
    Leyva, Laura
    Santos Thuler, Luiz Claudio
    Papais Alvarenga, Regina Maria
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2009, 214 (1-2) : 101 - 103
  • [47] Hydroxychloroquine for Primary Progressive Multiple Sclerosis
    Koch, Marcus W.
    Kaur, Sharanjit
    Sage, Kayla
    Kim, Janet
    Levesque-Roy, Myriam
    Cerchiaro, Graziela
    Yong, Voon Wee
    Cutter, Gary R.
    Metz, Luanne M.
    [J]. ANNALS OF NEUROLOGY, 2021, 90 (06) : 940 - 948
  • [48] Diagnosis of primary progressive multiple sclerosis
    Montalban, X
    [J]. NEUROLOGICAL SCIENCES, 2004, 25 : S31 - S31
  • [49] Treatment of Primary Progressive Multiple Sclerosis
    Kantarci, Orhun
    [J]. SEMINARS IN NEUROLOGY, 2013, 33 (01) : 74 - 77
  • [50] Neuropsychology of primary progressive multiple sclerosis
    Paes, R.
    Papais-Alvarenga, R.
    Vasconcelos, C.
    Negreiros, M. A.
    Landeira, J.
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 : 82 - 82
12345